Cargando…
Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides
Mutation-based treatments are a new development in genetic medicine, in which the nature of the mutation dictates the therapeutic strategy. Interest has recently focused on diseases caused by premature termination codons (PTCs). Drugs inducing the readthrough of these PTCs restore the production of...
Autores principales: | Floquet, Célia, Deforges, Jules, Rousset, Jean-Pierre, Bidou, Laure |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082906/ https://www.ncbi.nlm.nih.gov/pubmed/21149266 http://dx.doi.org/10.1093/nar/gkq1277 |
Ejemplares similares
-
Statistical Analysis of Readthrough Levels for Nonsense Mutations in Mammalian Cells Reveals a Major Determinant of Response to Gentamicin
por: Floquet, Célia, et al.
Publicado: (2012) -
Readthrough of Premature Termination Codons in the Adenomatous Polyposis Coli Gene Restores Its Biological Activity in Human Cancer Cells
por: Floquet, Célia, et al.
Publicado: (2011) -
Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives
por: Kawamoto, Steven A., et al.
Publicado: (2008) -
Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors
por: Zhang, Meiqiongzi, et al.
Publicado: (2018) -
LOOP IIId of the HCV IRES is essential for the structural rearrangement of the 40S-HCV IRES complex
por: Angulo, Jenniffer, et al.
Publicado: (2016)